Coriell Institute for Medical Research
Coriell Institute of Medical Research
  • Request a Quote
  • Donate
  • Login
  • View Cart
Sample Catalog | Custom Services | Core Facilities | Genomic Data Search
  • Biobank
    • NIGMS
    • NINDS
    • NIA
    • NHGRI
    • NEI
    • Allen Cell Collection
    • Rett Syndrome iPSC Collection
    • Autism Research Resource
    • HD Community Biorepository
    • CDC Cell and DNA
    • J. Craig Venter Institute
    • Orphan Disease Center Collection
    • All Biobanks
  • Research
    • Overview
    • Meet Our Scientists
      • Our Faculty
      • Our Scientific Staff
    • Camden Cancer Research Center
    • Epigenetic Therapies SPORE
    • Core Facilities
    • Epigenomics
    • Camden Opioid Research Initiative (CORI)
    • The Issa & Jelinek Lab
    • The Jian Huang Lab
    • The Luke Chen Lab
      • The Lab
      • The Team
      • Publications
    • The Scheinfeldt Lab
    • The Shumei Song Lab
    • The Nora Engel Lab
      • The Lab
      • The Team
      • Publications
    • Publications
  • Services
    • Overview
    • Biobanking Services
      • Core Services
      • Project Management
      • Research Support Services
      • Sample Cataloging
      • Sample Collection Kits
      • Sample Data Management
      • Sample Distribution
      • Sample Management
      • Sample Procurement
      • Sample Storage
    • Bioinformatics and Biostatistics Services
    • Cellular and Molecular Services
      • Biomarker Research Solutions
      • Cell Culture
      • Nucleic Acid Isolation and Quality Control
    • Clinical Trial Support
      • Overview
      • Sample Collection
      • Data Management
      • Sample Processing and QC
      • Storage and Distribution
      • Biomarker Services
      • Data Analaysis
    • Core Facilties
      • Overview
      • Animal and Xenograft
      • Bioinformatics and Biostatistics
      • Cell Imaging
      • CRISPR Gene Engineering
      • Flow Cytometry and Cell Sorting
      • Genomics and Epigenomics
      • iPSC - Induced Pluripotent Stem Cells
      • Organoids
    • Coriell Marketplace
    • Genomic, Epigenomic and Multiomics Services
    • Stem Cells and iPSC Services
      • Core Services
      • Reprogramming
      • Characterization and Quality Control
      • Differentiated Cell Lines
      • iPSC-Derived Organoids
      • iPSC Expansion
      • iPSC Gene Editing
  • Ordering
    • Stem Cells
    • Cell Lines
    • DNA and RNA
    • Featured Products
      • FFPE
      • HMW DNA
    • Genomic Data Search
    • Search by Catalog ID
    • Help
      • Create Account
      • Order Online
      • Ordering FAQ
      • FAQs/Culture Instructions
      • Reference Materials
        • Biobanks
        • NIGMS Repository
        • NHGRI Repository
        • NINDS Repository
        • NIA Repository
        • NIST
        • GeT-RM
      • Secondary Distribution Policies
      • MTA Assurance Form
      • Shipment Policy
      • Contact Customer Service
  • About Us
    • Our History
    • Meet Our Team
    • Meet Our Board
    • Education
      • Science Fair
      • Summer Experience
      • Outreach
      • Research Program Internship
    • Press Room
      • Press Releases
      • Coriell Blog
      • Annual Report
    • Careers
      • Working at Coriell
    • Giving
      • Donate
      • Giving FAQ
    • Contact Us
    • Legal Notice
  • Login View Cart
search submit
GM27857 iPSC from Fibroblast

Description:

CEREBRAL CREATINE DEFICIENCY SYNDROME 1; CCDS1
SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER, CREATINE), MEMBER 8; SLC6A8

Affected:

Yes

Sex:

Male

Age:

4 YR (At Sampling)

  • Overview
  • Characterizations
  • Phenotypic Data
  • External Links
  • Culture Protocols

Overview

back to top
Repository NIGMS Human Genetic Cell Repository
Subcollection Heritable Diseases
PIGI Consented Sample
Protocols Protocol PDF
Biopsy Source Skin
Cell Type Stem cell
Cell Subtype Induced pluripotent stem cell
Transformant Reprogrammed (Sendai)
Sample Source iPSC from Fibroblast
Race Asian
Ethnicity Not Hispanic/Latino
Ethnicity Romanian, Indian
Country of Origin USA
Family Member 1
Family History N
Relation to Proband proband
Confirmation Molecular characterization before cell line submission to CCR
ISCN 46,XY[20]
Species Homo sapiens
Common Name Human
Remarks Clinically affected; parental fibroblast is GM27448; See Phenotypic Data Tab. Researchers purchasing hiPSCs from the NIGMS Repository are responsible for any limited use label licenses (LULLs) applicable to the cell line purchased. The applicable LULL to this line is Sendai-CytoTune.

Characterizations

back to top
Passage Frozen 16
 
Induced Pluripotent Stem Cell The parental cell line was recovered, reprogrammed to an induced pluripotent stem cell line, and expanded. The expanded line was evaluated for viability surface antigen expression and alkaline phosphatase activity. Pluripotency was assessed via embryoid body (EB) formation. Steady-state mRNA expression patterns of undifferentiated iPSC and EBs were determined via real-time PCR. Characterization data are included in the Certificate of Analysis.
 
Gene SLC6A8
Chromosomal Location Xq28
Allelic Variant 1 ; CEREBRAL CREATINE DEFICIENCY SYNDROME 1
Identified Mutation DEL EX10-11

Phenotypic Data

back to top
Demographic Data
Relation to Proband proband
Age at Sampling 4 YR
Sex Male
Hispanic or Latino/Not Hispanic or Latino Not Hispanic/Latino
Racial Category Asian
Country USA
 
Data Elements
Clinical Element Type: General NIGMS Catalog Remarks
  (Baseline)
Mutation Information
Gene, variant, consequence, and exon number:  WHOLE GENOME SEQUENCING REVEALED X-LINKED HEMIZYGOUS MUTATION IN SLC6A8 CHRX:152959835-152960127, NOVEL VARIANT MOTHER IS LIKELY MOSAIC FATHER IS NEGATIVE; C3ORF20 CHR3:14798910, NOVEL VARIANT MOTHER IS NEGATIVE FATHER IS HETEROZYGOUS; C3ORF20 CHR3:14768516, RS13939744, MOTHER IS HETEROZYGOUS FATHER IS NEGATIVE; GNL2 CHR1:38039969, NOVEL VARIANT MOTHER IS NEGATIVE FATHER IS HETEROZYGOUS; GNL2 CHR1:38034840, RS371807683, MOTHER IS HETEROZYGOUS, FATHER IS NEGATIVE; HOMOPLASMIC VARIANT OF UNCERTAIN SIGNIFICANCE: M.4277T>C (TRNA ILE)
Zygosity:  Other
Notes: MOSAIC MUTATION IS PRESENT IN 10.38% OF CELLS
Age of Symptom Onset and Age at Diagnosis
Age of Symptom Onset:  1 YEAR
Age at Diagnosis:  2.5 YEARS
In Utero History Information
Additional Information:  MOTHER SCREENED FOR ELEVATED TSH; WAS ON THYROID REPLACEMENT THERAPY DURING PREGNANCY
Birth History Information
Dysmorphic Features
Neurological Symptoms
Optical and Audiological Symptoms
Musculoskeletal Symptoms
Developmental Milestones
Additional Information:  SAT UNSUPPORTED AT 8 MONTHS, BABBLED AT 10 MONTHS, CRUISED AT 11 MONTHS, CRAWLED AT 13-15 MONTHS; USED PINCER GRASP AT 12 MONTHS, AND WALKED INDEPENDENTLY AT 28 MONTHS; RECENTLY LOST SOME FINE MOTOR SKILLS; AT 1 YEAR AND 5 MONTHS OLD WAS AT THE FOLLOWING AGE-EQUIVALENT DEVELOPMENTAL LEVELS: 13 MONTHS OLD FOR ADAPTIVE BEHAVIOR, 10 MONTHS OLD FOR COGNITIVE, RECEPTIVE, COMMUNICATION, SOCIAL, AND GROSS MOTOR, 9 MONTHS OLD FOR EXPRESSIVE COMMUNICATION, 8 MONTHS OLD FOR FINE MOTOR; HISTORY OF BEING SMALL FOR AGE CATEGORY
Gastrointestinal Symptoms
Genitourinary Symptoms
Respiratory and Cardiovascular Symptoms
Cognitive and Behavioral Symptoms
Additional Information
Testing Performed
Metabolic, Hematologic, and Endocrinologic Testing:  ACYLCARNITINE PROFILE SHOWED BORDERLINE LOW FREE CARNITINE
Treatments and Assistive Devices
Occupational therapy
Physical therapy
Speech therapy
Orthotics
Communication or learning devices
Additional Testing:  MAGNETIC RESONANCE SPECTROSCOPY TESTING SHOWED LOW CREATINE PEAK; PSYCHOLOGICAL THERAPY; EAR TUBE SURGERY
Medications
Family History

External Links

back to top
Gene Cards SLC6A8
Gene Ontology GO:0001504 neurotransmitter uptake
GO:0005309 creatine:sodium symporter activity
GO:0005328 neurotransmitter:sodium symporter activity
GO:0005887 integral to plasma membrane
GO:0006836 neurotransmitter transport
GO:0006936 muscle contraction
GO:0015293 symporter activity
NCBI Gene Gene ID:6535
NCBI GTR 300036 SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER, CREATINE), MEMBER 8; SLC6A8
300352 CEREBRAL CREATINE DEFICIENCY SYNDROME 1; CCDS1
OMIM 300036 SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER, CREATINE), MEMBER 8; SLC6A8
300352 CEREBRAL CREATINE DEFICIENCY SYNDROME 1; CCDS1

Culture Protocols

back to top
Passage Frozen 16
Split Ratio 1:9
Temperature 37 C
Percent CO2 5%
Percent O2 AMBIENT
Medium Ham's F12 Medium/Dulbecco Modified Eagles Medium, 1:1 mixture with 2mM L-glutamine or equivalent
Serum 20% Knock-out Serum Replacement Not inactivated
Substrate Gelatin + Feeder Layer
Supplement -
Pricing
International/Commercial/For-profit:
$1,789.00USD
U.S. Academic/Non-profit/Government:
$1,110.00USD
Add to Cart
How to Order
  • Ordering Instructions
  • MTA / Assurance Form
  • Statement of Research Intent Form
Related Products
Same Subject
  • GM27448 - Fibroblast
  • GM28856 - Fibroblast
  • GM28954 - B-Lymphocyte
Same Family
  • 3486
Miscellaneous
  • DNA on Demand
  • Custom Services

Our mission is to prevent and cure disease through biomedical research.

CONTACT US

CUSTOMER SERVICE
customerservice@coriell.org (800) 752-3805 • (856) 757-4848
Subscribe to our newsletter here

Coriell Institute for Medical Research
403 Haddon Avenue Camden, NJ 08103, USA (856) 966-7377

Ⓒ 2025 Coriell Institute. All rights reserved.

  • Facebook
  • Linkedin
  • Youtube